Gaucher Patients Cope With Drug Shortage, as New Treatments Beckon

By Rebecca Dube

Published August 19, 2009, issue of August 28, 2009.
  • Print
  • Share Share

For thousands of people with Gaucher disease, the most common genetic disorder affecting Jews, the next few months will be challenging.

Many are going without the drug used to treat their potentially life-threatening enzyme disorder, after a virus contaminated a Boston-area manufacturing plant of biotechnology company Genzyme.

Meanwhile, Gaucher patients and their doctors are watching closely as the Food and Drug Administration is fast-tracking the approval process for two new treatments that would compete with Genzyme’s drug Cerezyme, which has had the market pretty much to itself until now.

“Of course there is anxiety,” said Rhonda Buyers, executive director of the National Gaucher Foundation. Because of the contamination at the Genzyme plant, supplies are limited and only the most vulnerable patients — children under 18 years old and adults with the most aggressive forms of the disease — are receiving regular doses of the drug. Everyone else has to wait until new doses of Cerezyme are available, which, according to Genzyme, may not be until November or December.

But there’s also hope, Buyers said. Partly in response to the plant contamination and drug shortage, the FDA has approved two new Gaucher drugs for limited compassionate and experimental use, one from the British-based pharmaceutical company Shire and another from Israel-based Protalix BioTherapeutics, raising the possibility that Gaucher patients won’t have to rely solely on Cerezyme in the future.

“If you have options, it’s just better than sitting there relying on one drug,” Buyers said.

Gaucher disease is caused by a genetic mutation, inherited from both parents, that results in a specific enzyme deficiency. According to Genzyme, fewer than 10,000 people worldwide have Gaucher disease. Symptoms may include enlargement of the liver and spleen, anemia, nose bleeds, easy bruising, bone pain and weakened bones. In the general population, about one in 100 people carry the gene for Gaucher disease; among Ashkenazic Jews, the carrier rate is one in 15. People can find out whether they carry the gene through a blood or saliva test.

Genzyme’s shutdown of its Allston, Mass., plant also stopped production of Fabrazyme, a drug to treat Fabry’s disease, another inherited enzyme disorder that causes lipid build-up in the body and increases the risk of heart attacks and strokes.

Kevin Kline of New Jersey was diagnosed with Gaucher disease when he was 5 years old, and he participated in the first clinical trials for the enzyme-replacement drug that eventually became Cerezyme. For the past 20 years, until last month, he has received injections of Cerezyme every two weeks; now he’s taking what he calls an “enzyme vacation.”

Kline, 37, hasn’t had any problems yet, and he is philosophical about the shortage.

“The Gaucher community is altruistic — we’re always looking out for each other,” he said. “People like myself are more than willing and capable of forgoing medication to help people who are more affected by the disease.”

People in the Gaucher community feel frustrated with Genzyme, he said, but at the same time Kline has a lot of gratitude for the fact that Cerezyme has been a “miracle” for him, allowing him to live basically symptom-free.

“It’s a tough situation,” Kline said. “While Genzyme has shown a lot of contrition, it doesn’t change the fact that we have a shortage.”

Like many other Gaucher patients, Kline and his doctor are monitoring his health and just waiting for Cerezyme to become available again this winter.

“We are in uncharted territory,” he said. “If I wake up one day and say, ‘Oh my God, I’m feeling the effects of not having the enzyme therapy,’ I’ll cross that bridge when I come to it.”


The Jewish Daily Forward welcomes reader comments in order to promote thoughtful discussion on issues of importance to the Jewish community. In the interest of maintaining a civil forum, The Jewish Daily Forwardrequires that all commenters be appropriately respectful toward our writers, other commenters and the subjects of the articles. Vigorous debate and reasoned critique are welcome; name-calling and personal invective are not. While we generally do not seek to edit or actively moderate comments, our spam filter prevents most links and certain key words from being posted and The Jewish Daily Forward reserves the right to remove comments for any reason.





Find us on Facebook!
  • "I am a Jewish woman married to a non-Jewish man who was raised Catholic, but now considers himself a “common-law Jew.” We are raising our two young children as Jews. My husband's parents are still semi-practicing Catholics. When we go over to either of their homes, they bow their heads, often hold hands, and say grace before meals. This is an especially awkward time for me, as I'm uncomfortable participating in a non-Jewish religious ritual, but don't want his family to think I'm ungrateful. It's becoming especially vexing to me now that my oldest son is 7. What's the best way to handle this situation?" http://jd.fo/b4ucX What would you do?
  • Maybe he was trying to give her a "schtickle of fluoride"...
  • It's all fun, fun, fun, until her dad takes the T-Bird away for Shabbos.
  • "Like many Jewish people around the world, I observed Shabbat this weekend. I didn’t light candles or recite Hebrew prayers; I didn’t eat challah or matzoh ball soup or brisket. I spent my Shabbat marching for justice for Eric Garner of Staten Island, Michael Brown of Ferguson, and all victims of police brutality."
  • Happy #NationalDogDay! To celebrate, here's a little something from our archives:
  • A Jewish couple was attacked on Monday night in New York City's Upper East Side. According to police, the attackers flew Palestinian flags.
  • "If the only thing viewers knew about the Jews was what they saw on The Simpsons they — and we — would be well served." What's your favorite Simpsons' moment?
  • "One uncle of mine said, 'I came to America after World War II and I hitchhiked.' And Robin said, 'I waited until there was a 747 and a kosher meal.'" Watch Billy Crystal's moving tribute to Robin Williams at last night's #Emmys:
  • "Americans are much more focused on the long term and on the end goal which is ending the violence, and peace. It’s a matter of zooming out rather than debating the day to day.”
  • "I feel great sorrow about the fact that you decided to return the honor and recognition that you so greatly deserve." Rivka Ben-Pazi, who got Dutchman Henk Zanoli recognized as a "Righteous Gentile," has written him an open letter.
  • Is there a right way to criticize Israel?
  • From The Daily Show to Lizzy Caplan, here's your Who's Jew guide to the 2014 #Emmys. Who are you rooting for?
  • “People at archives like Yad Vashem used to consider genealogists old ladies in tennis shoes. But they have been impressed with our work on indexing documents. Now they are lining up to work with us." This year's Jewish Genealogical Societies conference took place in Utah. We got a behind-the-scenes look:
  • What would Maimonides say about Warby Parker's buy-one, give-one charity model?
  • For 22 years, Seeds of Peace has fostered dialogue between Israeli and Palestinian teens in an idyllic camp. But with Israel at war in Gaza, this summer was different. http://jd.fo/p57AB
  • from-cache

Would you like to receive updates about new stories?




















We will not share your e-mail address or other personal information.

Already subscribed? Manage your subscription.